Traductor

25 February 2013

Sanofi Demonstrates Commitment to Innovative Diabetes Care at International Diabetes Technology Conference


 Sanofi  announced today that its comprehensive portfolio of innovative diabetes solutions will be presented at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris, France (February 27 - March 2). The annual ATTD conference is the leading diabetes technology meeting in Europe, and Sanofi will showcase its commitment to advancing therapeutic solutions and diabetes care technology aimed at improving patient outcomes.  
    Abstracts include the latest clinical data on the early benefits of Lantus(R) (insulin glargine), the accuracy, reliability and ease-of-use of the BGStar(R) and iBGStar(R) blood glucose meters, and the SoloSTAR(R) insulin delivery device. The study design of the biggest multi-national register of diabetes research in the young, TEENS, will also be featured.  
    In addition, Sanofi will sponsor a plenary satellite symposium at ATTD titled "Technology: Contributing to Diabetes Management Today and Tomorrow" which will provide an overview of current and future treatments, tools and projects to facilitate clinical decision making and empower patients to take control of their diabetes. The session will conclude with a presentation on the artificial pancreas in children.  
    "Today, effective diabetes management is increasingly a matter of simplifying day-to-day routines for people living with the condition. This means we need comprehensive approaches to diabetes care based on technological advances," said Pierre Chancel, Senior Vice President, Sanofi, Global Diabetes. "Sanofi's diabetes teams are dedicated to providing innovative and integrated technological solutions combined with patient support services that help people with diabetes effectively manage their disease while living the lives they want to live."  

No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud